Treatment of Radiation Sickness with Pyridoxine Hydrochloride in Outpatients of a Radiotherapy Unit

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

We think that the practical conclusion should be that treatment of radiation sickness with 1 or 2 mg. of pyridoxine hydrochloride orally t.d.s. by radiotherapists who are convinced of its efficacy gives very good results. Whether the effect of this low dose would differ from a placebo remains to be seen. The effect of the treatment of radiation sickness with pyridoxine hydrochloride was studied in outpatients of a radiotherapy unit. No significant difference between a very low (1 mg. t.d.s.) and a high dose (50 mg. t.d.s.) was detected. When, in case of failure of these doses, the daily dose was raised to 2 mg. t.d.s. and 100 mg. t.d.s., only a few patients in either group had to be treated with more potent drugs. © 1967, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Mattie, H., Emery, E. W., Hill, I. D., & Laurence, D. R. (1967). Treatment of Radiation Sickness with Pyridoxine Hydrochloride in Outpatients of a Radiotherapy Unit. British Medical Journal, 3(5559), 215–216. https://doi.org/10.1136/bmj.3.5559.215

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free